alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
EXHIBIT
32.2





CERTIFICATION
PURSUANT TO


SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002


(18
U.S.C. SECTION 1350)







In connection with the accompanying
Annual Report of Index Oil and Gas Inc. (the “Company”) on Form 10-K for
the period ended March 31, 2009 (the “Report”), I, Andrew Boetius, Chief
Financial Officer of the Company, hereby certify that to my
knowledge:





(1)           The
Report fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and





(2)           The
information contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of the Company.





Date:
      July 10, 2009
              By:
              /s/ Andrew
      BoetiusAndrew
      BoetiusChief
      Financial Officer
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONSOLIDATED FINANCIAL STATEMENTS CONTAINED IN THE BODY OF THE ACCOMPANYING FORM
10-Q AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH CONSOLIDATED
FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-END>                               SEP-30-1998
<CASH>                                          16,059
<SECURITIES>                                         0
<RECEIVABLES>                                   87,386
<ALLOWANCES>                                     4,530
<INVENTORY>                                     67,286
<CURRENT-ASSETS>                               187,045
<PP&E>                                         329,989
<DEPRECIATION>                                  47,406
<TOTAL-ASSETS>                                 725,176
<CURRENT-LIABILITIES>                           86,918
<BONDS>                                        523,750
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        64,836
<OTHER-SE>                                       4,876
<TOTAL-LIABILITY-AND-EQUITY>                   725,176
<SALES>                                        481,878
<TOTAL-REVENUES>                               481,878
<CGS>                                          399,751
<TOTAL-COSTS>                                  450,477
<OTHER-EXPENSES>                                 1,794
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              24,533
<INCOME-PRETAX>                                  5,074
<INCOME-TAX>                                     3,966
<INCOME-CONTINUING>                              1,108
<DISCONTINUED>                                   5,791
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     6,899
<EPS-PRIMARY>                                        0
<EPS-DILUTED>                                        0
        

</TABLE>
##### 



EXHIBIT 32.1


CERTIFICATION OF


PRINCIPAL EXECUTIVE OFFICER


PURSUANT TO 18 U.S.C. SECTION 1350


(SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002)






| |                                                                                                                                                                                                                                                                                                                   
| | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
| | (1) such Annual Report on Form 10-K of Odimo
    Incorporated for the fiscal year ended December 31, 2005,
    fully complies with the requirements of Section 13(a) or
    15(d) of the Securities Exchange Act of 1934, as amended; and                                                                         
|
| | (2) the information contained in such Annual Report on
    Form 10-K of Odimo Incorporated for the fiscal year ended
    December 31, 2005, fairly presents, in all material
    respects, the financial condition and results of operations of
    Odimo Incorporated at the dates and for the periods indicated.





| |                                      
| | -------------------------------------
| | /s/ Alan Lipton                      
| |                                      
| | Alan Lipton                          
| | President and Chief Executive Officer
| | (Principal Executive Officer)
#### Val. King *v.*Commonwealth.

Judges — Appointment—Presumption.

In the absence of a showing to the contrary, the Court of Appeals will presume that the provisions of the law as to the appointment of judges pro tempore were substantially complied with.

*399New Trial — Discretion of Court.

In penal prosecutions motions for new trials are addressed to the sound discretion of the trial court,

APPEAL FROM LOUISVILLE CITY COURT.

January 25, 1873.

*Demphey, for appellant.*

*'Attorney General, for appellee.*

Opinion by

Judge Lindsay :

It is insisted that the judgment in this case should be reversed.

First. Because the judge pro tem. who presided upon the trial of the prosecution was not sworn, and

Second. Because the sickness of the defendant prevented him from preparing his case for trial and from being present when tried and hence that the court erred in overruling his motion for a new trial. '

The record shows that the proceedings were had before a judge pro tem., and is silent as to whether or not he was sworn. It does not appear that he was selected to try this particular cause, and the plain, inference from all that appears is that he was selected to hold the term or some part thereof.

As we have not the order before us showing the proceedings at the trial of his selection we must presume that the provisions of the law were substantially complied with, and we are. strengthened in this conclusion by the fact that the alleged failure of the judge to take the oaths required by law is not made one of the grounds for a new trial.

As to the second ground relied upon in this court it is sufficient to say that in penal prosecutions motions, for new trials are addressed to the discretion of the judge of the criminal court. Subse. 3, Sec. 349, Criminal Code of Practice, prohibits this court from reversing a judgment of conviction for error of the judge of the court below in granting or refusing a new trial. The judgment must be *affirmed.*
February 2004 

Labeling Non-consumer Packages 

By Kathy Dresser 

The NIST Handbook 130 Uniform Packaging and Labeling Regulation (UPLR) was 

primarily written to address the packaging and labeling of products intended for retail 

sale. The UPLR refers to these packages as “Consumer Packages.” In addition, 

however, the UPLR also provides more limited information regarding the labeling of 

packages that the manufacturer or packer intended to be sold someplace other than at the 

retail level (e.g., wholesale, industrial, or institutional sales). The UPLR refers to these 

packages as “Non-consumer Packages,” and they have different, less stringent labeling 

requirements. 

Declaration of Identity. The declaration of identity must be the same as that for 

consumer packages, but must only appear on the outside of the package. The 

declaration of identity on a non-consumer package does not need to appear on the 

principal display panel, nor does it need to appear generally parallel to the base of the 

package. 

Declaration of Responsibility. The declaration of responsibility on a non-consumer 

package must contain the same information as that on a consumer package. 

Declaration of Quantity. The declar-ation of quantity on a non-consumer package must 

only be definitely and clearly stated in English on the outside of the package. There is no 

requirement that the declaration of quantity appear in the lower 30 percent of the 

principal display panel, or that it appear generally parallel to the base of the package. 

The declaration of quantity for a non-consumer package need not comply with the style 

of type, minimum type size, color contrast, or free area requirements for consumer 

packages. 

These broader, less stringent labeling requirements for non-consumer packages are 

intended to give the manufacturer or packer flexibility for warehousing and distributing 

pro-ducts that may be shipped by the pallet or crate. The information must be present, 

but the manufacturer or packer is given discretion regarding where and how it is provided 

to allow for different inventory and storage systems.
### D ISTRICT 

### C OURT 

### O F 

### A PPEAL 

### O F 

### T HE 

### S TATE 

### O F 

### F LORIDA

F OURTH D ISTRICT

HOWARD SCHWARTZ
, Appellant,

v.

SUNRISE LAKES CONDOMINIUM PHASE 4, INC. 3
and JUDY SCHWARTZ
, Appellee s

.

No. 4D 2 2

- 81

[ March 30, 2023 ]

Appeal from the C ircuit Court for the Seventeenth Judicial Circuit,
Broward County ; Carol

- L isa Phillips , Judge; L.T. Case No.

CACE18010992

.

Robert J. Mansen, David Stone, Ronnie Bronstein , and Aleksandra

Kravets of Mansfield Bronstein & Stone, LLP, Fort Lauderdale, for appellan t.

Ashley R. Tulloch and Jamie A.B. Rodriguez of Frank, Weinberg & Black, P.L., Plantation, for appellee Sunrise Lakes Condominium Phase 4,

Inc. 3

.

P ER C URIAM

.

Affirmed

.

K LINGENSMITH
, C.J., D AMOORGIAN and A RTAU
, JJ., concur

.

* * *

Not final until disposition of timely filed motion for rehearing.
##### 



EXHIBIT 32.1


CERTIFICATION OF


PRINCIPAL EXECUTIVE OFFICER


PURSUANT TO 18 U.S.C. SECTION 1350


(SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002)






| |                                                                                                                                                                                                                                                                                                                   
| | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
| | (1) such Annual Report on Form 10-K of Odimo
    Incorporated for the fiscal year ended December 31, 2004,
    fully complies with the requirements of Section 13(a) or
    15(d) of the Securities Exchange Act of 1934, as
    amended; and                                                                     
|
| | (2) the information contained in such Annual Report on
    Form 10-K of Odimo Incorporated for the fiscal year ended
    December 31, 2004, fairly presents, in all material
    respects, the financial condition and results of operations of
    Odimo Incorporated at the dates and for the periods indicated.





| |                                      
| | -------------------------------------
| | /s/ Alan Lipton                      
| |                                      
| | Alan Lipton                          
| | President and Chief Executive Officer
| | (Principal Executive Officer)
<PAGE>   1
 
                                                                   EXHIBIT 23.02
 
 CONSENT OF ARTHUR ANDERSEN LLP, INDEPENDENT PUBLIC ACCOUNTANTS, DATED JUNE 26,
                                      1998
 
     As independent public accountants, we hereby consent to the incorporation
by reference in this Registration Statement of our report dated May 14, 1997 on
the combined balance sheet of Carter Crowley Asset Group as of December 31, 1996
and the related combined statements of operations, shareholder's equity and cash
flows for each of the two years in the period ended December 31, 1996, included
in Crescent Operating, Inc.'s Annual Report on Form 10-K for the year ended
December 31, 1997 and to all references to our Firm included in or made a part
of this Registration Statement.
 
                                            /s/ ARTHUR ANDERSEN LLP
 
Dallas, Texas
June 26, 1998
[Federal Register Volume 79, Number 223 (Wednesday, November 19, 2014)]
[Notices]
[Page 68890]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2014-27384]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2014-N-1840]


Electronic Study Data Submission; Data Standards; Validation 
Rules for Study Data Tabulation Model Formatted Studies; Availability

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration's (FDA) Center for Drug 
Evaluation and Research (CDER) is announcing the availability of a 
document entitled ``Validation Rules for Study Data Tabulation Model 
(SDTM) Formatted Studies.'' CDER is making this document available to 
improve the standardization and quality of clinical data submitted to 
CDER, as well as to improve the predictability of data quality and 
usefulness.

FOR FURTHER INFORMATION CONTACT: Office of Strategic Programs, Center 
for Drug Evaluation and Research, Food and Drug Administration, 10903 
New Hampshire Ave., Bldg. 51, Rm. 1192, Silver Spring, MD 20993, email: 
<a href="/cdn-cgi/l/email-protection#e58081849184a5838184cb8d8d96cb828a93"><span class="__cf_email__" data-cfemail="523736332633123436337c3a3a217c353d24">[email protected]</span></a>.

SUPPLEMENTARY INFORMATION: CDER supports the regulatory submission of 
standardized clinical study data based on the Clinical Data Interchange 
Standards Consortium SDTM. Upon receipt of the data, CDER validates the 
data using a set of validation rules. The ``Validation Rules for SDTM 
Formatted Studies'' is an Excel file that provides a human readable 
description of a rule set for validation. Submitters of clinical study 
data can use this information to understand how FDA validates the data. 
The file is available on FDA's Study Data Standards Resources Web page 
at http://www.fda.gov/ForIndustry/DataStandards/StudyDataStandards/default.htm. It contains a combination of conformance rules (i.e., how 
well the data conform to the standard) and business rules (i.e., 
quality checks; how well the data may support useful analysis). The 
rules may be updated periodically as new or updated validation rules 
are developed. The Change History tab will provide a descriptive change 
history of the document.

    Dated: November 14, 2014.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2014-27384 Filed 11-18-14; 8:45 am]
BILLING CODE 4164-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
URICINAL

IN THE SUPREME COURT OF THE STATE OF MONTANA

THE OFFICE OF THE CLERK OF SUPREME COURT

HELENA, MONTANA 59620-3003

Supreme Court No.

DA 20-0186

JACOB SMITH,

Plaintiff and Appellant,

v.

MICHAEL ROOPE,

Defendant and Appellee.

FILED

MAY 0 4 2020

Bovven Greenwood

Clerk of Supreme Court

State of Montana

GRANT OF EXTENSION

Pursuant to authority granted under M. R. App.P. 26(1), Appellant is given an extension of time

until June 1, 2020, to prepare, file, and serve the Appellant's brief.

DATED this May 4, 2020

Bowen Greenwood

Clerk of the Supreme Court

c: Jacob Smith, Michael Roope, Michael Donahoe

PO BOX 203003 • HELENA MT • 59620-3003 • TELEPHONE: (406) 444-3858 • FAX: (406) 444-5705

05/04/2020

Case Number: DA 20-0186
Affiliate Members

October 2023

February 2023

AFFILIATES

Joel Dean

Letitia Everist

Martin Herman

Amanda Hunter

Anthony Koertner

Steven Lund

Brian McVicker

Lisa Ragaza

Ian St. Laurent

Alicia Wilcox
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Commerce

###### Foreign-Trade Zones Board

          - [S-143-2014]

An application has been submitted to the Foreign-Trade Zones Board (the Board) by the City of Waco, grantee of FTZ 246, requesting subzone status for the facility of Spenco Medical Corporation, located in Waco, Texas. The application was submitted pursuant to the provisions of the Foreign-Trade Zones Act, as amended (19 U.S.C. 81a-81u), and the regulations of the Board (15 CFR part 400). It was formally docketed on November 17, 2014.

The proposed subzone (12.9 acres) is located at 6301 Imperial Drive in Waco. The proposed subzone would be subject to the existing activation limit of FTZ 246. No authorization for production activity has been requested at this time.

In accordance with the Board's regulations, Camille Evans of the FTZ Staff is designated examiner to review the application and make recommendations to the Executive Secretary.

Public comment is invited from interested parties. Submissions shall be addressed to the Board's Executive Secretary at the address below. The closing period for their receipt is December 31, 2014. Rebuttal comments in response to material submitted during the foregoing period may be submitted during the subsequent 15-day period to January 15, 2015.

                    A copy of the application will be available for public inspection at the Office of the Executive Secretary, Foreign-Trade Zones Board, Room 21013, U.S. Department of Commerce, 1401 Constitution Avenue NW., Washington, DC 20230-0002, and in the “Reading Room” section of the Board's Web site, which is accessible via                     *www.trade.gov/​ftz.*

                    For further information, contact Camille Evans at                     *Camille.Evans@trade.gov*                     or (202) 482-2350.                

Dated: November 17, 2014.

Andrew McGilvray,

Executive Secretary.

[FR Doc. 2014-27676 Filed 11-20-14; 8:45 am]

BILLING CODE 3510-DS-P
Exhibit 23.1

 

 

 

 

 

 

 

 

 

Consent of Independent Registered Public Accounting Firm

 

The Board of Directors

Plug Power Inc.:

We consent to the incorporation by reference in the registration statements on Form S-8 (Nos. 333-41863, 333-72841, 333-76817) and Form S-3 (Nos. 333-112464), and Form S-1 (No. 333-121868) of Mechanical Technology Incorporated of our report dated February 7, 2003, except as to Note 15, which is as of March 25, 2003, with respect to the consolidated balance sheet of Plug Power Inc. and subsidiary as of December 31, 2002, and the related consolidated statements of operations, stockholders' equity, and cash flows for the year then ended, which report appears in Form 10-K/A (Amendment No. 1 to the annual report on Form 10-K) of Mechanical Technology Incorporated for the year ended December 31, 2002.

Our report refers to cumulative consolidated statements of operations, stockholders' equity, and cash flows for the period June 27, 1997 (inception) to December 31, 2002 which include amounts for the period from June 27, 1997 (inception) to December 31, 1997 and for each of the years in the three-year period ending December 31, 2000, which were audited by other auditors whose report has been furnished to us, and our opinion, insofar as it relates to the amounts included for the period June 27, 1997 through December 31, 2000 is based solely on the report of other auditors.

/s/ KPMG LLP 

 

 

Albany, New York

March 21, 2005
<PAGE>   1
                                                                     EXHIBIT 4-F

                              CERTIFICATE OF TRUST


                 The undersigned, the trustees of Phillips 66 Capital VI,
desiring to form a business trust pursuant to Section 3810 of the Delaware
Business Trust Act, 12 Del. C. Section  3810, hereby certify as follows:

                 (a)      The name of the business trust being formed hereby
                          (the "Trust") is "Phillips 66 Capital VI".

                 (b)      The name and business address of the trustee of the
                          Trust which has its principal place of business in
                          the State of Delaware is as follows:

                                  The Bank of New York (Delaware)
                                  White Clay Center, Route 273
                                  Newark, Delaware 19711

                 (c)      This Certificate of Trust shall be effective as of
                          the date of filing.


Dated:  May 22, 1998


                                        /s/ T.C. Morris                       
                                        --------------------------------------
                                        Name:  T.C. Morris
                                        Title: Trustee


                                        /s/ John A. Carrig                    
                                        --------------------------------------
                                        Name:  John A. Carrig
                                        Title: Trustee


                                        /s/ R.B. Gisi                         
                                        --------------------------------------
                                        Name:  R.B. Gisi
                                        Title: Trustee


                                        THE BANK OF NEW YORK (DELAWARE), as 
                                        Trustee


                                        By: /s/  Mary Jane Morrissey          
                                           -----------------------------------
                                           Name:  Mary Jane Morrissey
                                           Title: Authorized Signatory
Order entered August 1 4 , 2013

In The 

## Court of Appeals Fifth District of Texas at Dallas

No. 05

- 12

- 01000

- CV

RUSSELL D. ABEREGG, Appellant

V.
MONICA CESCHAN, Appellee
On Appeal from the 330th Judicial District Court

Dallas County, Texas Trial Court Cause No. DF

- 12

- 00023



### O RDER
Before the Court is appellant’s August 1, 2013 motion for clarification of this Court’s order dated July 2, 2013. Appellant believes this Court ordered him to file an amended brief by August 1, 2013. He now seeks a thirty da y extension of time to file a brief. Appellant filed a brief on May 20, 2013. On May 23, 2013, this Court sent appellant a defective brief notice and instructed him to file an amended brief correcting the deficiencies within ten days. Appellant did not file an amended brief as instructed. On July 2, 2013, we ordered that the appeal would be submitted on the brief appellant initially filed and ordered it
filed as of the date of the order. This Court then stated that appellee’s brief was due within thir ty days. Accordingly, we DENY appellant’s motion to the extent that he requests an extension of
time to file a brief.
/s/ DAVID LEWIS JUSTICE